Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure-Reference-Cited by-同舟云学术

Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure

Published:2019-06 Issue:23 Volume:73 Page:3038-3039
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Aimo Alberto,Emdin Michele,Maisel Alan S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Effects of sacubitril/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF;Zile;J Am Coll Cardiol,2019

2. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment;Konstam;J Am Coll Cardiol Img,2011

3. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study;Masci;Circ Cardiovasc Imaging,2013

4. Biomarker-assist score for reverse remodeling prediction in heart failure: the ST2-R2 score;Lupón;Int J Cardiol,2015

5. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure;Gaggin;J Am Coll Cardiol HF,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology;Journal of Clinical Medicine;2023-01-12

2. Diagnostic and therapeutic potential of protease inhibition;Molecular Aspects of Medicine;2022-12

3. Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium–glucose co-transporter 2 inhibitors?;Future Cardiology;2021-05

4. Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure;Current Cardiology Reviews;2020-09-10

5. Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences;Journal of Clinical Medicine;2020-03-25